A study in rats hints that exposure to dim light at night may make human breast cancer tumors resistant to the chemotherapy drug doxorubicin.However, giving the rats a melatonin supplement prevented this light-linked resistance to doxorubicin, the most widely used cancer chemotherapy drug in the world.Prior rat-based research by the same investigators found that exposure to dim light at night boosted human breast cancer tumors’ resistance to the breast cancer drug tamoxifen.
Hey, check out all the engineering jobs. Post your resume today!